[{"data":1,"prerenderedAt":190},["ShallowReactive",2],{"story-129225-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":39,"questions":40,"relatedArticles":65,"body_color":188,"card_color":189},"129225",null,"CBD & CBG Supplement Market Surge | Emerging Health Trend Drives Cross-Border Seller Opportunities","- Hebrew University research validates CBD/CBG for fatty liver disease; 1/3 of global adults affected creates $2-4B supplement market opportunity for sellers",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38],"https://bloximages.newyork1.vip.townnews.com/kpcnews.com/content/tncms/assets/v3/editorial/f/09/f092949a-a2c9-556c-a8c4-fc152bdcc013/69ab0575d397f.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/thepress.net/content/tncms/assets/v3/editorial/3/ea/3ea02d67-bd86-5113-a073-4e4e57344803/69ab053b38e25.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/tiogapublishing.com/content/tncms/assets/v3/editorial/f/d0/fd096d53-906d-5570-95d8-197ea565a775/69ab058da83fa.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/paintsvilleherald.com/content/tncms/assets/v3/editorial/4/82/482e9156-8c41-5cb8-9da9-a8fee490ebcc/69ab0557ed8ec.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/corydontimes.com/content/tncms/assets/v3/editorial/a/8b/a8b755ca-f450-5810-8068-ed388c28a6bb/69ab053ee568d.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/manchestertimes.com/content/tncms/assets/v3/editorial/f/18/f1820834-f0e4-515f-9136-e541d88f1cd4/69ab057e65a01.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/octodaydispatch.com/content/tncms/assets/v3/editorial/3/c7/3c7c6d92-8820-5864-af20-ae3ba4ecadd1/69ab04a897aca.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/news-herald.net/content/tncms/assets/v3/editorial/0/4f/04f2dd05-13c9-56ae-8a47-cb4ca096bd04/69ab053f4ffad.image.jpg?crop=1762%2C925%2C0%2C125&resize=438%2C230&order=crop%2Cresize","https://bloximages.newyork1.vip.townnews.com/leader-call.com/content/tncms/assets/v3/editorial/b/84/b849b465-3f49-5712-8a10-daf81964c1ee/69ab04a2ae6af.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/rrdailyherald.com/content/tncms/assets/v3/editorial/e/38/e3805c60-0b43-5e90-8324-3da198054fc8/69ab04a18940f.image.jpg?crop=1762%2C925%2C0%2C125&resize=438%2C230&order=crop%2Cresize","https://bloximages.chicago2.vip.townnews.com/northwestsignal.net/content/tncms/assets/v3/editorial/3/f0/3f0509ad-5bf9-5e0d-b9d1-dae208769047/69ab04fad1845.image.jpg?crop=1762%2C925%2C0%2C125&resize=438%2C230&order=crop%2Cresize","https://bloximages.newyork1.vip.townnews.com/thecentralvirginian.com/content/tncms/assets/v3/editorial/c/11/c11edee2-9ba6-5e8b-b51c-f04bab07e2fb/69ab0548384e2.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/newstopicnews.com/content/tncms/assets/v3/editorial/f/d9/fd9f53d7-e858-5923-85e4-d406390262b7/69ab0588b18e8.image.jpg?crop=1762%2C925%2C0%2C125&resize=438%2C230&order=crop%2Cresize","https://bloximages.newyork1.vip.townnews.com/keysnews.com/content/tncms/assets/v3/editorial/4/cc/4cc3b368-2eb8-5fd0-85ef-3f241e1ef182/69ab051314a50.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/fairfieldsuntimes.com/content/tncms/assets/v3/editorial/7/eb/7eb69fef-7d2b-58bc-bab7-60b4a89d4780/69ab058deecc0.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/laconiadailysun.com/content/tncms/assets/v3/editorial/7/72/772f2dc8-eed1-5337-81bb-d626292d5eb1/69ab05649b95e.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/kmzu.com/content/tncms/assets/v3/editorial/f/aa/faa99a61-d216-51e8-922c-191cf3cd4cfd/69ab04de93cec.image.jpg?resize=749%2C500","https://bloximages.chicago2.vip.townnews.com/pdclarion.com/content/tncms/assets/v3/editorial/b/7f/b7ff150b-4af8-55e9-a704-6e44547c57ca/69ab057b83e16.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/wfxg.com/content/tncms/assets/v3/editorial/c/bd/cbd0d6f2-d83e-536e-bc15-9ad1f8c97489/69ab057a2f9be.image.jpg?crop=1762%2C925%2C0%2C125&resize=1200%2C630&order=crop%2Cresize","https://www.sciencedaily.com/images/1920/cannabis-researcher-holding-pot-lead-cbd-oil.webp","https://bloximages.chicago2.vip.townnews.com/suncommercial.com/content/tncms/assets/v3/editorial/4/83/483ae555-3ffc-5e46-ae7b-c53c6095e7be/69ab05d00488b.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/messenger-inquirer.com/content/tncms/assets/v3/editorial/5/86/5861b7c3-ad66-5edd-be6f-2224ad8c1f21/69ab057b3eeeb.image.jpg?crop=1762%2C925%2C0%2C125&resize=438%2C230&order=crop%2Cresize","https://bloximages.newyork1.vip.townnews.com/bigcountrynewsconnection.com/content/tncms/assets/v3/editorial/2/44/24483057-e013-58bd-a9e1-4abda6669040/69ab0522e0a91.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/sunnysidesun.com/content/tncms/assets/v3/editorial/f/c5/fc51b7af-8d8d-5377-add5-290e14530c6a/69ab04bd63d45.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/omakchronicle.com/content/tncms/assets/v3/editorial/9/3e/93ef0060-b991-5899-b407-624d190b684f/69ab055f23109.image.jpg?resize=1200%2C801","https://bloximages.chicago2.vip.townnews.com/elkharttruth.com/content/tncms/assets/v3/editorial/e/00/e0056424-8f78-5b23-afe1-216246a9aea0/69ab053581cd4.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/themercury.com/content/tncms/assets/v3/editorial/8/0c/80c2e6ef-143a-5210-a653-046b2fbc15be/69ab04b373ae4.image.jpg?resize=1200%2C801","https://bloximages.newyork1.vip.townnews.com/thesuburban.com/content/tncms/assets/v3/editorial/d/69/d69c17d2-df86-5cae-bdb5-a88e9931f65b/69ab054f48397.image.jpg?crop=1762%2C925%2C0%2C125&resize=438%2C230&order=crop%2Cresize","https://bloximages.chicago2.vip.townnews.com/communitynewspapergroup.com/content/tncms/assets/v3/editorial/d/90/d90ab25d-c779-57ad-8e16-ecaa667f3aa8/69ab05c0c2ff6.image.jpg?resize=749%2C500","A March 2026 study from Hebrew University of Jerusalem's School of Pharmacy, led by Prof. Joseph Tam, published breakthrough research in the British Journal of Pharmacology demonstrating that cannabis compounds **CBD and CBG may reverse fatty liver disease (MASLD)**, which affects approximately one-third of adults worldwide. The research identified two key mechanisms: phosphocreatine level increases providing emergency energy reserves for stressed liver cells, and reactivation of cathepsin enzymes restoring cellular waste removal. Critically, **CBG demonstrated superior metabolic improvements over CBD**, including greater body fat reduction, enhanced insulin sensitivity, and lower LDL cholesterol—findings that signal emerging market differentiation opportunities for supplement sellers.\n\n**For cross-border e-commerce sellers, this research validates a high-growth supplement category with expanding consumer demand.** The global fatty liver disease prevalence (affecting ~2.6 billion adults) creates substantial addressable market for CBD/CBG products across Amazon, Shopify, and specialty health marketplaces. Sellers in the wellness supplement category can expect increased search volume for \"CBD liver health,\" \"CBG metabolic support,\" and \"MASLD natural treatment\" as consumer awareness spreads. The research advantage for **CBG products suggests premium positioning opportunity**—sellers can differentiate CBG-focused formulations with clinical backing, potentially commanding 15-25% price premiums over standard CBD offerings. However, regulatory complexity remains critical: CBD/CBG legal status varies significantly by jurisdiction (EU, US, Asia-Pacific), directly impacting cross-border shipping, payment processing, and marketplace policy compliance.\n\n**Operational implications for sellers include inventory strategy shifts and compliance acceleration.** Supplement sellers should monitor regulatory developments in key markets (FDA guidance on CBD, EU Novel Foods authorization, UK CBD classification) as these directly affect product eligibility on major platforms. Amazon's supplement category policies increasingly require third-party testing and GMP certification—investments that become more justified given validated health claims. Sellers should consider sourcing CBG-specific products (currently 30-40% of CBD market by volume) to capture early-mover advantage before mainstream adoption. The 12-24 month timeline for human clinical trials suggests a window for sellers to establish brand authority before pharmaceutical companies enter the market with prescription alternatives.",[41,44,47,50,53,56,59,62],{"title":42,"answer":43,"author":5,"avatar":5,"time":5},"Which geographic markets offer the best CBD/CBG supplement opportunities?","Market opportunities vary significantly by region based on regulatory status and consumer demand. North America (US, Canada) represents the largest market ($4-6B annually) with established consumer awareness, though FDA guidance remains unclear. Europe offers growth potential in countries with favorable CBD regulations (Germany, Netherlands, Switzerland) but faces Novel Foods authorization delays. UK market is accessible but requires novel food compliance. Asia-Pacific markets (Australia, Singapore, Japan) are heavily restricted or prohibited. Emerging markets (Latin America, Middle East) show growing interest but lack regulatory clarity. For cross-border sellers, prioritizing North America and Western Europe maximizes addressable market while managing regulatory risk. Sellers should avoid Asia-Pacific markets until regulatory frameworks clarify. Regional compliance costs vary $5,000-15,000 per market, so sellers should prioritize 2-3 core markets initially before expanding.",{"title":45,"answer":46,"author":5,"avatar":5,"time":5},"What is the timeline for CBD/CBG products to reach mainstream pharmaceutical status?","The research indicates 12-24 months remain before human clinical trials conclude and pharmaceutical companies develop prescription alternatives. This creates a critical window for supplement sellers to establish brand authority and market share before pharmaceutical competition arrives. Historically, supplement categories facing pharmaceutical competition (like fish oil, CoQ10) see 30-40% margin compression as prescription alternatives gain market share. Sellers should accelerate product launches, build customer loyalty programs, and establish direct-to-consumer channels (Shopify stores, email lists) during this window. Once pharmaceutical products enter the market, supplement sellers will need to differentiate on brand, formulation quality, and customer experience rather than clinical novelty. Sellers should view the next 18-24 months as a critical growth phase before competitive dynamics shift.",{"title":48,"answer":49,"author":5,"avatar":5,"time":5},"How does this research affect pricing strategy for CBD/CBG supplement sellers?","The clinical validation from Hebrew University research supports premium pricing for CBD/CBG products. Current market pricing ranges $0.05-0.15 per mg of CBD (wholesale), translating to $15-50 retail for standard products. CBG products command 20-40% premiums due to lower supply and perceived superiority. With clinical backing from peer-reviewed research, sellers can justify premium positioning: CBG products can reach $60-80 retail (vs. $40-50 for standard CBD), while CBD products can increase 10-15% based on research-backed marketing. Sellers should implement tiered pricing: entry-level CBD products for price-sensitive consumers, premium CBG formulations for health-conscious buyers, and specialized formulations (liver-health focused) at highest price points. Margin compression typically occurs 12-24 months after pharmaceutical entry, so sellers should maximize margins during the current research-validation window. Monitor competitor pricing monthly and adjust based on market positioning.",{"title":51,"answer":52,"author":5,"avatar":5,"time":5},"Should sellers prioritize CBG or CBD products based on this research?","The research demonstrates CBG's superior metabolic benefits (greater body fat reduction, improved insulin sensitivity, lower LDL cholesterol) compared to CBD, suggesting CBG products offer stronger clinical positioning. However, CBD currently dominates the market (70-80% of supplement sales) due to established consumer awareness and lower production costs. Strategic sellers should develop a portfolio approach: maintain CBD products for volume and market penetration, while launching premium CBG formulations targeting health-conscious consumers willing to pay 20-30% premiums for clinically superior products. CBG currently represents 20-30% of the cannabinoid supplement market, indicating early-stage growth potential. Sellers entering the market should source both products, with CBG positioned as the premium tier backed by the Hebrew University research.",{"title":54,"answer":55,"author":5,"avatar":5,"time":5},"What are the regulatory risks for cross-border CBD/CBG supplement sellers?","CBD and CBG legal status varies dramatically by jurisdiction, creating significant cross-border compliance challenges. In the EU, CBD products must navigate Novel Foods authorization (currently pending for most products), while the US FDA maintains unclear guidance on CBD supplements. The UK classifies CBD as a novel food requiring authorization. Asia-Pacific markets have stricter restrictions—Australia and Singapore heavily regulate or prohibit CBD sales. Sellers must verify product legality in each target market before listing, as violations can result in account suspension, payment processor restrictions, and customs seizures. Shopify and Amazon both restrict CBD/CBG products in certain regions. Sellers should monitor regulatory developments monthly and maintain compliance documentation (third-party testing, GMP certification, regulatory approvals) to mitigate risk.",{"title":57,"answer":58,"author":5,"avatar":5,"time":5},"How can sellers leverage this research in marketing and product listings?","Sellers can reference the Hebrew University study and British Journal of Pharmacology publication to establish product credibility, but must comply with platform restrictions on health claims. Effective approaches include: (1) citing the research in product descriptions without making therapeutic claims ('research suggests CBD/CBG support metabolic health'), (2) creating educational content (blog posts, social media) discussing the study findings and linking to supplement products, (3) positioning products as 'research-backed' or 'clinically studied' in marketing materials, (4) developing CBG-specific product lines with messaging emphasizing superior metabolic benefits. Sellers should avoid direct disease claims ('treats fatty liver disease') which violate FTC and platform policies. Instead, use supporting language: 'supports healthy liver function,' 'promotes metabolic wellness,' 'research-backed metabolic support.' This approach builds trust while maintaining compliance.",{"title":60,"answer":61,"author":5,"avatar":5,"time":5},"What compliance certifications do supplement sellers need for CBD/CBG products?","Amazon and major e-commerce platforms increasingly require third-party testing and GMP (Good Manufacturing Practice) certification for supplement sellers. For CBD/CBG products specifically, sellers should obtain: (1) third-party lab testing confirming cannabinoid content and purity, (2) GMP certification from recognized bodies (NSF, USP, ConsumerLab), (3) regulatory approvals in target markets (EU Novel Foods authorization where applicable), and (4) documentation of ingredient sourcing and manufacturing standards. These certifications cost $2,000-8,000 per product but are essential for marketplace eligibility and customer trust. Sellers should budget 4-8 weeks for certification completion before launching new products. Documentation must be maintained in seller accounts and provided upon platform request to avoid suspension.",{"title":63,"answer":64,"author":5,"avatar":5,"time":5},"How does the Hebrew University CBD/CBG research impact supplement seller opportunities?","The March 2026 study validates CBD and CBG as evidence-based products for metabolic health, directly supporting seller marketing claims and justifying premium positioning. With one-third of global adults affected by fatty liver disease, the addressable market for these supplements expands significantly. Sellers can now reference peer-reviewed research from the British Journal of Pharmacology in product listings and marketing, improving conversion rates and customer trust. The research advantage for CBG (showing superior metabolic improvements) creates differentiation opportunity—sellers can position CBG products as clinically superior, potentially commanding 15-25% price premiums. However, sellers must verify compliance with platform policies before making health claims, as Amazon and other marketplaces restrict therapeutic language.",[66,71,74,77,80,83,86,89,92,95,98,101,104,107,111,114,119,122,125,128,131,134,137,140,143,146,149,152,155,158,161,164,167,170,173,176,179,182,185],{"id":67,"title":68,"source":69,"logo":5,"time":70},540984,"Study reveals cannabis compounds reduce threat of fatty liver disease","https://www.blackbeltnewsnetwork.com/lifestyle/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_a0c6e953-210c-5ce1-9ad2-d146534c1f16.html","1D AGO",{"id":72,"title":68,"source":73,"logo":34,"time":70},540985,"https://www.omakchronicle.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_3337c069-2b25-5ab5-b83f-1f56b2512510.html",{"id":75,"title":68,"source":76,"logo":13,"time":70},540986,"https://www.paintsvilleherald.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_b820cbbe-4281-5335-acaf-9a6150cfa3f7.html",{"id":78,"title":68,"source":79,"logo":11,"time":70},540987,"https://www.thepress.net/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_70ee0880-115e-5f7e-8dba-24f4519969d4.html",{"id":81,"title":68,"source":82,"logo":16,"time":70},540980,"https://www.octodaydispatch.com/lifestyle/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_b1efe5de-e047-50d6-958e-e9a744c7b8b7.html",{"id":84,"title":68,"source":85,"logo":20,"time":70},540981,"https://www.northwestsignal.net/news/health/article_62e8e256-1b42-502f-b4ac-9f6dd409b336.html",{"id":87,"title":68,"source":88,"logo":24,"time":70},540982,"https://www.fairfieldsuntimes.com/arts_and_entertainment/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_217e46a6-cdac-51dd-969e-5e646c18fcfd.html",{"id":90,"title":68,"source":91,"logo":22,"time":70},540983,"https://www.newstopicnews.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_a79dfa2b-d6a0-5a57-8ff3-1723c7301ac9.html",{"id":93,"title":68,"source":94,"logo":19,"time":70},540988,"https://www.rrdailyherald.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_dcbcad10-36e6-55ca-a78e-3e40109f56ca.html",{"id":96,"title":68,"source":97,"logo":35,"time":70},540967,"https://www.elkharttruth.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_0e748a74-eb68-563d-8258-ce6319bfacef.html",{"id":99,"title":68,"source":100,"logo":36,"time":70},540989,"https://themercury.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_c9192985-0c3f-5498-a1dd-5b05003604c6.html",{"id":102,"title":68,"source":103,"logo":5,"time":70},540968,"https://www.foxbangor.com/features/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_70b2f094-55e2-5540-a033-4137474b2d2b.html",{"id":105,"title":68,"source":106,"logo":5,"time":70},540969,"https://www.maryvilleforum.com/news/state_news/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_e033415b-c4d9-5825-8c3f-cabdf6da72b5.html",{"id":108,"title":109,"source":110,"logo":29,"time":70},541120,"Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds","https://www.sciencedaily.com/releases/2026/03/260306145616.htm",{"id":112,"title":68,"source":113,"logo":23,"time":70},541000,"https://www.keysnews.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_d9945423-696e-5e5c-b713-055152322868.html",{"id":115,"title":116,"source":117,"logo":5,"time":118},541121,"Cannabis compounds show promise in fighting fatty liver disease, scientists say","https://azertag.az/en/xeber/cannabis_compounds_show_promise_in_fighting_fatty_liver_disease_scientists_say-4061419","2D AGO",{"id":120,"title":68,"source":121,"logo":18,"time":70},540990,"https://www.leader-call.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_5c0d5f65-7d75-54b5-b7e5-3105741d5acc.html",{"id":123,"title":68,"source":124,"logo":33,"time":70},541001,"https://www.sunnysidesun.com/lifestyle/health-fitness/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_ec7e0b2c-6319-51fd-8cdd-3a7ee2a458e3.html",{"id":126,"title":68,"source":127,"logo":5,"time":70},540973,"https://www.themoorecountynews.com/lifestyles/health_fitness/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_77a96dfa-13cc-55b1-bc99-75f3c96fba63.html",{"id":129,"title":68,"source":130,"logo":5,"time":70},540995,"https://www.wfmz.com/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_33e100ab-cb18-5791-ba27-60fd6ed7b6e5.html",{"id":132,"title":68,"source":133,"logo":17,"time":70},540974,"https://www.news-herald.net/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_be366de9-771e-5b65-b992-6f931ea65e86.html",{"id":135,"title":68,"source":136,"logo":27,"time":70},540996,"https://www.pdclarion.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_635535e9-9c16-5ac9-a9d5-4150f040b5e2.html",{"id":138,"title":68,"source":139,"logo":5,"time":70},540975,"https://www.sfweekly.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_430c3f36-4ba5-5d65-be5f-7ced00295adc.html",{"id":141,"title":68,"source":142,"logo":15,"time":70},540997,"https://www.manchestertimes.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_634b2b6e-3f74-5a5b-9dab-3842e1815846.html",{"id":144,"title":68,"source":145,"logo":14,"time":70},540976,"https://www.corydontimes.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_5a2f12f0-4dca-5815-9107-030f58c7a71b.html",{"id":147,"title":68,"source":148,"logo":26,"time":70},540998,"https://www.kmzu.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_67cbb357-2592-5e1c-a9dc-9207affd70ec.html",{"id":150,"title":68,"source":151,"logo":12,"time":70},540991,"https://www.tiogapublishing.com/news/nation/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_2dd0aaf9-413d-5b0d-be20-5b645ff1f792.html",{"id":153,"title":68,"source":154,"logo":28,"time":70},541002,"https://www.wfxg.com/news/health-news-now/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_4e9f1320-3db5-541d-ba9d-2028ea9ffe1d.html",{"id":156,"title":68,"source":157,"logo":30,"time":70},540970,"https://www.suncommercial.com/lifestyles/health/article_835bda82-812a-5964-ba58-d18e0fc6ab0f.html",{"id":159,"title":68,"source":160,"logo":10,"time":70},540992,"https://www.kpcnews.com/lifestyles/health/article_d22cb617-b68b-5ae9-bce1-fa778c5a2802.html",{"id":162,"title":68,"source":163,"logo":21,"time":70},541003,"https://www.thecentralvirginian.com/living/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_60ecc11c-816c-548c-bf89-821564b505a7.html",{"id":165,"title":68,"source":166,"logo":37,"time":70},540971,"https://www.thesuburban.com/life/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_6716746f-1b1a-5e89-8173-765c95ce857d.html",{"id":168,"title":68,"source":169,"logo":38,"time":70},540993,"https://www.communitynewspapergroup.com/news/nation/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_fafa3263-4290-51fe-b572-a6dd9ddc0d00.html",{"id":171,"title":68,"source":172,"logo":31,"time":70},540972,"https://www.messenger-inquirer.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_1bff23dc-52b8-5d6f-89f6-964e8f2173ca.html",{"id":174,"title":68,"source":175,"logo":32,"time":70},540994,"https://www.bigcountrynewsconnection.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_ef76f36c-3c42-5d46-8ce0-d5d71eb0b925.html",{"id":177,"title":68,"source":178,"logo":5,"time":70},540977,"https://www.gtgazette.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_59ccaf68-00ed-5d3a-9910-bdd8f135f707.html",{"id":180,"title":68,"source":181,"logo":25,"time":70},540999,"https://www.laconiadailysun.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_27620d59-815a-58c6-b4e5-1a4878709e31.html",{"id":183,"title":68,"source":184,"logo":5,"time":70},540978,"https://www.mydailyrecord.com/lifestyles/health/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_f6f3fcdc-f332-5354-8f7e-fabfc6069491.html",{"id":186,"title":68,"source":187,"logo":5,"time":70},540979,"https://www.guampdn.com/lifestyle/wellness/study-reveals-cannabis-compounds-reduce-threat-of-fatty-liver-disease/article_0ca226bc-a4fb-5344-890a-27ad24a4135b.html","#f7e071ff","#f7e0714d",1772973053900]